MBX Biosciences, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2024 | $-10.7M | $-11.0M | $273.0K | $1.6M |
| Jun 2024 | $-13.3M | $-13.7M | $452.0K | $919.0K |
| Sep 2024 | $-14.7M | $-14.7M | $57.0K | $1.2M |
| Dec 2024 | $-16.0M | $-16.1M | $92.0K | $1.5M |
| Mar 2025 | $-22.7M | $-22.7M | $30.0K | $1.8M |
| Jun 2025 | $-17.4M | $-18.1M | $707.0K | $1.9M |
| Sep 2025 | $-21.5M | $-21.9M | $399.0K | $2.2M |
| Dec 2025 | $-18.3M | $-19.1M | $793.0K | $2.7M |
| Mar 2026 | $-20.2M | $-20.6M | $437.0K | $5.5M |
| Jun 2026 | $-22.6M | $-23.5M | $901.0K | $6.1M |